Key result
Lipomatous hypertrophy of the interatrial septum can obstruct bicaval cannulation, requiring direct SVC or jugular access.
Why the study?
Lipomatous hypertrophy of the interatrial septum is a rare benign cardiac condition, and possible pitfalls during bicaval cannulation in this circumstance warranted description.
Case Report (n=1)
No
Lipomatous hypertrophy of the interatrial septum can present pitfalls during bicaval cannulation, with surgical therapy reserved for those with SVC obstruction or rhythm disturbances.
Answers are grounded in this paper and cite their sources.
May prompt alternative cannulation in LHIS; leaves open need for systematic evaluation before practice change.
BACKGROUND: Lipomatous hypertrophy of the interatrial septum is a rare benign cardiac condition characterized by fatty tissue infiltration of the septum. CASE PRESENTATION: We presented some interesting images and some possible pitfalls during the cannulation in this circumstance. CONCLUSION: Surgical therapy appears to be reserved to patients with SVC obstruction or any rhythm disturbances.
No takes yet. Share an insight, caveat, or question.
Baikoussis et al. (2023) conducted a case report in Lipomatous hypertrophy of the interatrial septum (n=1). Bicaval cannulation and surgical resection of lipomatous hypertrophy of the interatrial septum was evaluated. Lipomatous hypertrophy of the interatrial septum can obstruct the superior vena cava and impede right atrial bicaval cannulation, warranting direct SVC or jugular cannulation during cardiac surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: